Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Assets Average (2016 - 2025)

Historic Assets Average for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to $18.7 million.

  • Abvc Biopharma's Assets Average rose 13648.74% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year increase of 13648.74%. This contributed to the annual value of $7.1 million for FY2024, which is 1252.28% down from last year.
  • Latest data reveals that Abvc Biopharma reported Assets Average of $18.7 million as of Q3 2025, which was up 13648.74% from $15.6 million recorded in Q2 2025.
  • Abvc Biopharma's 5-year Assets Average high stood at $18.7 million for Q3 2025, and its period low was $7.3 million during Q1 2024.
  • Over the past 5 years, Abvc Biopharma's median Assets Average value was $11.1 million (recorded in 2021), while the average stood at $11.2 million.
  • Per our database at Business Quant, Abvc Biopharma's Assets Average tumbled by 3893.87% in 2024 and then soared by 13648.74% in 2025.
  • Abvc Biopharma's Assets Average (Quarter) stood at $13.0 million in 2021, then dropped by 23.0% to $10.0 million in 2022, then increased by 16.15% to $11.6 million in 2023, then crashed by 34.26% to $7.7 million in 2024, then skyrocketed by 144.28% to $18.7 million in 2025.
  • Its Assets Average was $18.7 million in Q3 2025, compared to $15.6 million in Q2 2025 and $11.2 million in Q1 2025.